These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 32491224)
41. Multi-Echo Quantitative Susceptibility Mapping for Strategically Acquired Gradient Echo (STAGE) Imaging. Gharabaghi S; Liu S; Wang Y; Chen Y; Buch S; Jokar M; Wischgoll T; Kashou NH; Zhang C; Wu B; Cheng J; Haacke EM Front Neurosci; 2020; 14():581474. PubMed ID: 33192267 [TBL] [Abstract][Full Text] [Related]
42. Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencing. Deh K; Kawaji K; Bulk M; Van Der Weerd L; Lind E; Spincemaille P; McCabe Gillen K; Van Auderkerke J; Wang Y; Nguyen TD Magn Reson Med; 2019 Feb; 81(2):1229-1236. PubMed ID: 30284727 [TBL] [Abstract][Full Text] [Related]
43. Quantitative magnetic susceptibility mapping without phase unwrapping using WASSR. Lim IA; Li X; Jones CK; Farrell JA; Vikram DS; van Zijl PC Neuroimage; 2014 Feb; 86():265-79. PubMed ID: 24113625 [TBL] [Abstract][Full Text] [Related]
45. Cerebral OEF quantification: A comparison study between quantitative susceptibility mapping and dual-gas calibrated BOLD imaging. Ma Y; Sun H; Cho J; Mazerolle EL; Wang Y; Pike GB Magn Reson Med; 2020 Jan; 83(1):68-82. PubMed ID: 31373088 [TBL] [Abstract][Full Text] [Related]
46. QSM reconstruction challenge 2.0: A realistic in silico head phantom for MRI data simulation and evaluation of susceptibility mapping procedures. Marques JP; Meineke J; Milovic C; Bilgic B; Chan KS; Hedouin R; van der Zwaag W; Langkammer C; Schweser F Magn Reson Med; 2021 Jul; 86(1):526-542. PubMed ID: 33638241 [TBL] [Abstract][Full Text] [Related]
47. Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data. Chen J; Gong NJ; Chaim KT; Otaduy MCG; Liu C Neuroimage; 2021 Nov; 242():118477. PubMed ID: 34403742 [TBL] [Abstract][Full Text] [Related]
48. Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group. ; Bilgic B; Costagli M; Chan KS; Duyn J; Langkammer C; Lee J; Li X; Liu C; Marques JP; Milovic C; Robinson SD; Schweser F; Shmueli K; Spincemaille P; Straub S; van Zijl P; Wang Y; Magn Reson Med; 2024 May; 91(5):1834-1862. PubMed ID: 38247051 [TBL] [Abstract][Full Text] [Related]
49. Simultaneous QSM and metabolic imaging of the brain using SPICE. Peng X; Lam F; Li Y; Clifford B; Liang ZP Magn Reson Med; 2018 Jan; 79(1):13-21. PubMed ID: 29067730 [TBL] [Abstract][Full Text] [Related]
50. Phase-based masking for quantitative susceptibility mapping of the human brain at 9.4T. Hagberg GE; Eckstein K; Tuzzi E; Zhou J; Robinson S; Scheffler K Magn Reson Med; 2022 Nov; 88(5):2267-2276. PubMed ID: 35754142 [TBL] [Abstract][Full Text] [Related]
52. Multi-centre, multi-vendor reproducibility of 7T QSM and R Rua C; Clarke WT; Driver ID; Mougin O; Morgan AT; Clare S; Francis S; Muir KW; Wise RG; Carpenter TA; Williams GB; Rowe JB; Bowtell R; Rodgers CT Neuroimage; 2020 Dec; 223():117358. PubMed ID: 32916289 [TBL] [Abstract][Full Text] [Related]
53. Echo-time dependency of quantitative susceptibility mapping reproducibility at different magnetic field strengths. Lancione M; Donatelli G; Cecchi P; Cosottini M; Tosetti M; Costagli M Neuroimage; 2019 Aug; 197():557-564. PubMed ID: 31075389 [TBL] [Abstract][Full Text] [Related]
54. Integrated Laplacian-based phase unwrapping and background phase removal for quantitative susceptibility mapping. Li W; Avram AV; Wu B; Xiao X; Liu C NMR Biomed; 2014 Feb; 27(2):219-27. PubMed ID: 24357120 [TBL] [Abstract][Full Text] [Related]
55. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study. Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483 [TBL] [Abstract][Full Text] [Related]
56. Maximum spherical mean value filtering for whole-brain QSM. Roberts AG; Romano DJ; Şişman M; Dimov AV; Nguyen TD; Kovanlikaya I; Gauthier SA; Wang Y; Spincemaille P Magn Reson Med; 2024 Apr; 91(4):1586-1597. PubMed ID: 38169132 [TBL] [Abstract][Full Text] [Related]
57. On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping. Eskreis-Winkler S; Zhou D; Liu T; Gupta A; Gauthier SA; Wang Y; Spincemaille P Magn Reson Imaging; 2017 Jan; 35():154-159. PubMed ID: 27587225 [TBL] [Abstract][Full Text] [Related]
58. Quantitative Susceptibility Mapping at 3 T and 1.5 T: Evaluation of Consistency and Reproducibility. Hinoda T; Fushimi Y; Okada T; Fujimoto K; Liu C; Yamamoto A; Okada T; Kido A; Togashi K Invest Radiol; 2015 Aug; 50(8):522-30. PubMed ID: 25900085 [TBL] [Abstract][Full Text] [Related]
59. Deep learning-based quantitative susceptibility mapping (QSM) in the presence of fat using synthetically generated multi-echo phase training data. Hanspach J; Bollmann S; Grigo J; Karius A; Uder M; Laun FB Magn Reson Med; 2022 Oct; 88(4):1548-1560. PubMed ID: 35713187 [TBL] [Abstract][Full Text] [Related]
60. A modulated closed form solution for quantitative susceptibility mapping--a thorough evaluation and comparison to iterative methods based on edge prior knowledge. Khabipova D; Wiaux Y; Gruetter R; Marques JP Neuroimage; 2015 Feb; 107():163-174. PubMed ID: 25463463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]